Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
American Journal of Physiology. Heart and Circulatory Physiology|June 14, 2002
Differences in E2F subunit expression in quiescent and proliferating vascular smooth muscle cellsNobuya Fujita, Yusuke Furukawa, Naoki Itabashi, et al.
Kidney International|October 2, 2004
Spironolactone prevents early renal injury in streptozotocin-induced diabetic ratsGenro Fujisawa, Koji Okada, Shigeaki Muto, et al.
Hypertension (Dallas, Tex. : 1979)|March 8, 2003
Na/H exchange isoform 1 is involved in mineralocorticoid/salt-induced cardiac injuryGenro Fujisawa, Koji Okada, Shigeaki Muto, et al.
Molecular and Cellular Endocrinology|June 29, 2002
Hyperglycemia enhances VSMC proliferation with NF-kappaB activation by angiotensin II and E2F-1 augmentation by growth factorsNobuya Fujita, Yusuke Furukawa, Jian Du, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 25, 2018
Effect of canagliflozin on nocturnal home blood pressure in Japanese patients with type 2 diabetes mellitus: The SHIFT-J studyKazuomi Kario, Satoshi Hoshide, Yukie Okawara, et al.
Diabetes Research and Clinical Practice|September 29, 2005
Diabetic lipemia with eruptive xanthomatosis in a lean young female with apolipoprotein E4/4Satoshi Shinozaki, Naoki Itabashi, Kumiko Rokkaku, et al.
Endocrine Journal|January 8, 2004
Unilateral adrenalectomy improves insulin resistance and diabetes mellitus in a patient with ACTH-independent macronodular adrenal hyperplasiaManabu Ogura, Ikuyo Kusaka, Shoichiro Nagasaka, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 21, 2008
Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout miceToshihiro Inaba, Hiroaki Yagyu, Naoki Itabashi, et al.
Kidney International Reports|July 9, 2025
Dotinurad Treatment for Patients With Hyperuricemia Complicating CKDKatsuyuki Tanabe, Tomokazu Nunoue, Naoki Itabashi, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 6, 2023
Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study)Masahiro Sugawara, Masahiro Fukuda, Ichiro Sakuma, et al.
Pageof 2